Organization
Feinstein Institute For Medical Research, Manhasset
2 abstracts
Abstract
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF-OF-CONCEPT STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SIRUKUMAB IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS Org: The Karolinska University Hospital, Stockholm, Sweden, Feinstein Institute For Medical Research, Manhasset, The Ohio State University College of Medicine, Columbus, Janssen R & D, LLC, Spring House, United States,
Abstract
Attainment of low disease activity and remission in systemic lupus erythematosus patients with high disease activity in the atacicept phase iib address ii study and its long-term extensionOrg: Monash University School of Public Health and Preventive Medicine, Oklahoma Medical Research Foundation, Arthritis & Clinical Immunology, Oklahoma City, United States of America, University College London, Centre for Rheumatology, Division of Medicine, London, United Kingdom, EMD Serono Research and Development Institute, Inc. (a business of Merck KGaA, Darmstadt, Germany), Feinstein Institute For Medical Research, Manhasset,